中国学术期刊网络出版总库入编期刊
CNKI中文期刊全文数据库全文收录期刊
中国核心期刊(遴选)数据库全文收录期刊
万方数据——数字化期刊群收录期刊
中文科技期刊数据库全文收录期刊

主管:陕西省卫生健康委员会
主办:西安心身医学研究所
   西安交通大学第一附属医院
国际标准刊号:ISSN2096—1413
国内统一刊号:CN61—1503/R

阿托伐他汀钙联合曲美他嗪治疗冠心病的效果观察

卫娇娜1 ,王永进1 ,王众国2 ,高宏波1

(陕西省汉中市人民医院心血管内科:1.一病区;2.二病区,陕西 汉中,723000)

浏览次数:165次 下载次数:426次

摘要:

目的 探讨曲美他嗪与阿托伐他汀钙联用治疗冠心病的临床效果。方法 选择我院收治并确诊为冠心病的患者90例, 随机将其分为对照组和治疗组,每组45例。对照组患者单纯采用阿托伐他汀钙治疗,治疗组患者采用曲美他嗪与阿托伐他汀钙两种药物联合治疗。对比两组患者治疗前、后的CRP水平、冠心病药物治疗效果、心电图表现恢复正常时间和冠心病药 物治疗总时间、不良反应发生情况。结果 治疗后,治疗组患者CRP水平的改善幅度明显大于对照组(P<0.05);且治疗组患者冠心病药物治疗效果明显优于对照组(P<0.05);治疗组患者心电图表现恢复正常时间和冠心病药物治疗总时间明显短于对照组(P<0.05);治疗组患者用药导致的不良反应明显少于对照组(P<0.05)。结论 曲美他嗪与阿托伐他汀钙两种药物联合应用,对冠心病患者实施治疗的临床效果非常明显。

关键词:曲美他嗪;阿托伐他汀钙;冠心病

中图分类号:R541.4文献标志码:A文章编号:2096-1413(2017)14-0038-02

    Effect of atorvastatin calcium combined with trimetazidine on coronary heart disease
    WEI Jiao-na 1, WANG Yong-jin 1, WANG Zhong-guo 2, GAO Hong-bo 1
    (1. the 1st Ward; 2. the 2nd Ward, Department of Cardiology, the People`s Hospital of Hanzhong, Hanzhong 723000, Chin
    a)

    ABSTRACT: Objective To study the Effect of atorvastatin calcium combined with trimetazidine on coronary heart disease. Methods Ninety cases of patients diagnosed with coronary heart disease in our hospital were selected and randomly divided into control group and treatment group, with 45 cases in each group. The control group was treated with atorvastatin calcium alone, while the treatment group was treated with trimetazidine and atorvastatin calcium. The CRP levels, coronary heart disease drug treatment effect, ECG performance returned to normal time and total time of coronary heart disease drug treatment, adverse reactions of the two groups before and after treatment were compared. Results After treatment, the improvement of CRP in the treatment group was significantly higher than that in the control group (P<0.05); the coronary heart disease drug treatment effect in the treatment group was significantly better than that in the control group (P<0.05); the ECGperformance returned to normal time and total time in the treatment group were shorter than those in the control group (P<0.05); the adverse reactions caused by medication in the treatment group were significantly less than those in the control group (P<0.05). Conclusion Atorvastatin calcium combined with trimetazidine has obvious curative effect on patients with coronary heart disease.
    KEYWORDS:trimetazidine; atorvastatin calcium; coronary heart disease

    参考文献:
    [1] 谢芳.阿托伐他汀联合曲美他嗪治疗冠心病的疗效研究[J].实用心脑肺血管病杂志,2014,22(11):29-30.
    [2] 周帅.应用阿托伐他汀结合曲美他嗪治疗冠心病患者的临床效果观察[J].中国医药指南,2015,13(6):139-140.
    [3] 朱云.曲美他嗪、阿托伐他汀两药物合用治疗冠心病的疗效分析 [J].现代诊断与治疗,2012,23(5):597.
    [4] 赖汉齐,傅万颖,麦佩琼.阿托伐他汀联合曲美他嗪治疗稳定型心绞痛效果分析[J].当代医学,2013,19(5):40-41.
    [5] 吴仕君,王胜梅.冠心病患者血清Hcy 和Cys C水平的变化[J].检验医学,2014,29(4):327-328.
    [6] 张瑞红,相秀英,王晶锐,等.阿托伐他汀钙对冠心病患者颈动脉粥样硬化斑块的影响[J].实用临床医药杂志,2014,18(7):84-85.
    [7] 陈翀昊,王广燕,苏衡.瑞舒伐他汀与阿托伐他汀对早发冠心病急性心肌梗死患者的近期疗效[J].中国临床药理学杂志,2013,29(2):126-128.

    [8] 丁百炼,张幼婷.瑞舒伐他汀治疗老年冠心病患者高胆固醇血症的临床研究[J].吉林医学,2012,33(15):3200-3201.

上一篇不同剂量阿托伐他汀在冠心病治疗中不良反应的临床观察

下一篇寻常型鱼鳞病合手足皲裂症运用复方乳酸软膏治疗的临床效果